Cargando…

A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods

SUMMARY: In a randomized, cross-over study, once monthly administration of vitamin D3 was preferred over a once daily administration of a fixed-dose combination of vitamin D3 and calcium, with a better compliance but without any significant difference in the increase in vitamin D levels. INTRODUCTIO...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruyère, O., Deroisy, R., Dardenne, N., Cavalier, E., Coffiner, M., Da Silva, S., De Niet, S., Reginster, J.-Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656705/
https://www.ncbi.nlm.nih.gov/pubmed/26100413
http://dx.doi.org/10.1007/s00198-015-3205-z
_version_ 1782402273411858432
author Bruyère, O.
Deroisy, R.
Dardenne, N.
Cavalier, E.
Coffiner, M.
Da Silva, S.
De Niet, S.
Reginster, J.-Y.
author_facet Bruyère, O.
Deroisy, R.
Dardenne, N.
Cavalier, E.
Coffiner, M.
Da Silva, S.
De Niet, S.
Reginster, J.-Y.
author_sort Bruyère, O.
collection PubMed
description SUMMARY: In a randomized, cross-over study, once monthly administration of vitamin D3 was preferred over a once daily administration of a fixed-dose combination of vitamin D3 and calcium, with a better compliance but without any significant difference in the increase in vitamin D levels. INTRODUCTION: The aim of the present study was to compare a once-monthly administration of vitamin D3 to a daily administration of a fixed-dose combination of vitamin D3 and calcium during two treatment periods of 6 months. METHODS: One hundred volunteers aged 50 years old or older were randomized to receive either one drinkable ampoule containing 25,000 IU vitamin D3 (D-Cure®, SMB) once monthly (group VD) or one chewable tablet containing 1000 mg calcium carbonate + 800 IU vitamin D3 (Steovit Forte®, Takeda) once daily (group VDCa) during 6 months. After the first 6 months of treatment, the groups were reversed according to the randomized cross-over design. Treatment compliance (i.e. the primary outcome), preference, acceptability and vitamin D levels and adverse events were all collected. RESULTS: For the two periods, the patients had a significantly higher compliance in the VD group than in the VDCa group (p < 0.0001). During the study, 50 (56.8 %) patients preferred the VD treatment, 16 (18.2 %) patients preferred the VDCa, and for 22 (25.0 %) patients, neither treatment was preferred. At the end of the first 6 months of treatment, the mean (SD) increase of 25(OH)D was 6.57 ng/mL (8.19) in the VD group and 3.88 ng/mL (10.0) in the VDCa group (p = 0.16 between groups). CONCLUSION: In this study, a once-monthly administration of vitamin D3 was preferred over a once-daily administration of a fixed-dose combination of vitamin D3 and calcium, with a better compliance but without any significant difference in the increase in vitamin D levels.
format Online
Article
Text
id pubmed-4656705
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer London
record_format MEDLINE/PubMed
spelling pubmed-46567052015-12-01 A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods Bruyère, O. Deroisy, R. Dardenne, N. Cavalier, E. Coffiner, M. Da Silva, S. De Niet, S. Reginster, J.-Y. Osteoporos Int Original Article SUMMARY: In a randomized, cross-over study, once monthly administration of vitamin D3 was preferred over a once daily administration of a fixed-dose combination of vitamin D3 and calcium, with a better compliance but without any significant difference in the increase in vitamin D levels. INTRODUCTION: The aim of the present study was to compare a once-monthly administration of vitamin D3 to a daily administration of a fixed-dose combination of vitamin D3 and calcium during two treatment periods of 6 months. METHODS: One hundred volunteers aged 50 years old or older were randomized to receive either one drinkable ampoule containing 25,000 IU vitamin D3 (D-Cure®, SMB) once monthly (group VD) or one chewable tablet containing 1000 mg calcium carbonate + 800 IU vitamin D3 (Steovit Forte®, Takeda) once daily (group VDCa) during 6 months. After the first 6 months of treatment, the groups were reversed according to the randomized cross-over design. Treatment compliance (i.e. the primary outcome), preference, acceptability and vitamin D levels and adverse events were all collected. RESULTS: For the two periods, the patients had a significantly higher compliance in the VD group than in the VDCa group (p < 0.0001). During the study, 50 (56.8 %) patients preferred the VD treatment, 16 (18.2 %) patients preferred the VDCa, and for 22 (25.0 %) patients, neither treatment was preferred. At the end of the first 6 months of treatment, the mean (SD) increase of 25(OH)D was 6.57 ng/mL (8.19) in the VD group and 3.88 ng/mL (10.0) in the VDCa group (p = 0.16 between groups). CONCLUSION: In this study, a once-monthly administration of vitamin D3 was preferred over a once-daily administration of a fixed-dose combination of vitamin D3 and calcium, with a better compliance but without any significant difference in the increase in vitamin D levels. Springer London 2015-06-23 2015 /pmc/articles/PMC4656705/ /pubmed/26100413 http://dx.doi.org/10.1007/s00198-015-3205-z Text en © The Author(s) 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Bruyère, O.
Deroisy, R.
Dardenne, N.
Cavalier, E.
Coffiner, M.
Da Silva, S.
De Niet, S.
Reginster, J.-Y.
A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods
title A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods
title_full A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods
title_fullStr A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods
title_full_unstemmed A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods
title_short A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods
title_sort phase iv, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin d3 to compliance with daily administration of a fixed-dose combination of vitamin d3 and calcium during two 6-month periods
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656705/
https://www.ncbi.nlm.nih.gov/pubmed/26100413
http://dx.doi.org/10.1007/s00198-015-3205-z
work_keys_str_mv AT bruyereo aphaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods
AT deroisyr aphaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods
AT dardennen aphaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods
AT cavaliere aphaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods
AT coffinerm aphaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods
AT dasilvas aphaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods
AT deniets aphaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods
AT reginsterjy aphaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods
AT bruyereo phaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods
AT deroisyr phaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods
AT dardennen phaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods
AT cavaliere phaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods
AT coffinerm phaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods
AT dasilvas phaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods
AT deniets phaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods
AT reginsterjy phaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods